Technical Analysis for SRNE - Sorrento Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 2.1 -6.67% -0.15
SRNE closed down 6.67 percent on Friday, August 23, 2019, on 57 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical SRNE trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
20 DMA Resistance Bearish -6.67%
Bearish Engulfing Bearish -6.67%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -6.67%
Wide Bands Range Expansion -6.67%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -9.09%
Wide Bands Range Expansion -9.09%
20 DMA Resistance Bearish -7.89%
Bearish Engulfing Bearish -7.89%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -7.89%

Older signals for SRNE ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Sorrento Therapeutics, Inc., a development stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel and proprietary biotherapeutics for the treatment of cancer, inflammation, metabolic, and infectious diseases in the United States. The company's G-MAB, a human antibody library platform, facilitates the rapid identification and isolation of highly specific antibody therapeutic product candidates that bind to disease targets appropriate for antibody therapy. Its human antibody library technology is used to construct large human antibody libraries. It has license agreement with OPKO Health, Inc. to develop, manufacture, use, market, sell, offer to sell, import, and export certain products related to the development, manufacture, marketing, and sale of drugs for ophthalmological indications. Sorrento Therapeutics, Inc. is based in San Diego, California.
Medicine Health Biotechnology Biopharmaceutical Cancer Biology Immunology Disease Infectious Diseases Treatment Of Cancer Immune System Inflammation Antibody Monoclonal Antibody Antibody Therapy
Is SRNE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.5
52 Week Low 1.8
Average Volume 1,128,645
200-Day Moving Average 2.9662
50-Day Moving Average 2.647
20-Day Moving Average 2.2925
10-Day Moving Average 2.18
Average True Range 0.1443
ADX 14.64
+DI 18.999
-DI 26.0059
Chandelier Exit (Long, 3 ATRs ) 2.4771
Chandelier Exit (Short, 3 ATRs ) 2.4629
Upper Bollinger Band 2.6895
Lower Bollinger Band 1.8955
Percent B (%b) 0.26
BandWidth 34.634678
MACD Line -0.1173
MACD Signal Line -0.1387
MACD Histogram 0.0214
Fundamentals Value
Market Cap 144.84 Million
Num Shares 69 Million
EPS -0.66
Price-to-Earnings (P/E) Ratio -3.19
Price-to-Sales 10.91
Price-to-Book 1.87
PEG Ratio -0.06
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.40
Resistance 3 (R3) 2.43 2.36 2.35
Resistance 2 (R2) 2.36 2.28 2.35 2.33
Resistance 1 (R1) 2.23 2.24 2.20 2.20 2.32
Pivot Point 2.16 2.16 2.14 2.15 2.16
Support 1 (S1) 2.03 2.08 2.00 2.00 1.88
Support 2 (S2) 1.96 2.04 1.95 1.87
Support 3 (S3) 1.83 1.96 1.85
Support 4 (S4) 1.80